GSTM1 and neoplasm: We first showed that GL261 cell proliferation is not affected by β-HB treatment per se and that these cells are not consuming ketone bodies in vitro, one evidence supported by the increased concentration of β-HB in the tumor tissue of KD mice [5] and by the absence of intracellular β-HB in GL261 cells.